These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 8705395)

  • 1. A phase I safety and pharmacokinetic study of a recombinant amino terminal fragment of bactericidal/permeability-increasing protein in healthy male volunteers.
    Bauer RJ; White ML; Wedel N; Nelson BJ; Friedmann N; Cohen A; Hustinx WN; Kung AH
    Shock; 1996 Feb; 5(2):91-6. PubMed ID: 8705395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of a recombinant modified amino terminal fragment of bactericidal/permeability-increasing protein (rBPI21) in healthy volunteers.
    Bauer RJ; Wedel N; Havrilla N; White M; Cohen A; Carroll SF
    J Clin Pharmacol; 1999 Nov; 39(11):1169-76. PubMed ID: 10579148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of liver and kidney on the pharmacokinetics of a recombinant amino terminal fragment of bactericidal/permeability-increasing protein in rats.
    Bauer RJ; Der K; Ottah-Ihejeto N; Barrientos J; Kung AH
    Pharm Res; 1997 Feb; 14(2):224-9. PubMed ID: 9090714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Organ blood flow after partial hepatectomy in rats: modification by endotoxin-neutralizing bactericidal/permeability-increasing protein (rBPI23).
    Boermeester MA; Houdijk AP; Straatsburg IH; van Noorden CJ; van Leeuwen PA
    J Hepatol; 1999 Nov; 31(5):905-12. PubMed ID: 10580589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alteration of the pharmacokinetics of small proteins by iodination.
    Bauer RJ; Leigh SD; Birr CA; Bernhard SL; Fang M; Der K; Ihejeto NO; Carroll SF; Kung AH
    Biopharm Drug Dispos; 1996 Dec; 17(9):761-74. PubMed ID: 8968529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant amino terminal fragment of bactericidal/permeability-increasing protein prevents hemodynamic responses to endotoxin.
    Ammons WS; Kung AH
    Circ Shock; 1993 Nov; 41(3):176-84. PubMed ID: 8269647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A recombinant amino terminal fragment of bactericidal/permeability-increasing protein inhibits the induction of leukocyte responses by LPS.
    Mészáros K; Parent JB; Gazzano-Santoro H; Little R; Horwitz A; Parsons T; Theofan G; Grinna L; Weickmann J; Elsbach P
    J Leukoc Biol; 1993 Dec; 54(6):558-63. PubMed ID: 8245707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase 1 dose-escalating study to evaluate the safety, pharmacokinetics, and pharmacodynamics of a recombinant factor Xa variant (FXa
    Parsons-Rich D; Hua F; Li G; Kantaridis C; Pittman DD; Arkin S
    J Thromb Haemost; 2017 May; 15(5):931-937. PubMed ID: 28294526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effects of a recombinant N-terminal fragment of bactericidal/permeability increasing protein on endotoxic shock in conscious rabbits.
    Lin Y; Ammons WS; Leach WJ; Kung AH
    Shock; 1994 Nov; 2(5):324-31. PubMed ID: 7743357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional domains of recombinant bactericidal/permeability increasing protein (rBPI23).
    Little RG; Kelner DN; Lim E; Burke DJ; Conlon PJ
    J Biol Chem; 1994 Jan; 269(3):1865-72. PubMed ID: 8294435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and pharmacokinetic results with a new ultrashort-acting calcium antagonist, clevidipine, following gradually increasing intravenous doses to healthy volunteers.
    Ericsson H; Fakt C; Jolin-Mellgård A; Nordlander M; Sohtell L; Sunzel M; Regårdh CG
    Br J Clin Pharmacol; 1999 May; 47(5):531-8. PubMed ID: 10336577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. rBPI23 attenuates endotoxin-induced cardiovascular depression in awake rabbits.
    Koyama S; Shibamoto T; Ammons WS; Saeki Y
    Shock; 1995 Jul; 4(1):74-8. PubMed ID: 7552782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A recombinant amino-terminal fragment of bactericidal/permeability increasing protein (rBPI23) inhibits soluble CD14-mediated lipopolysaccharide-induced endothelial adherence for human neutrophils.
    Huang K; Conlon PJ; Fishwild DM
    Shock; 1994 Feb; 1(2):81-6. PubMed ID: 7538431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The recombinant 23-kDa N-terminal fragment of bactericidal/permeability-increasing protein (rBPI23) decreases Escherichia coli-induced mortality and organ injury during immunosuppression-related neutropenia.
    Lechner AJ; Lamprech KE; Johanns CA; Matuschak GM
    Shock; 1995 Oct; 4(4):298-306. PubMed ID: 8564560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effect of a recombinant fragment of bactericidal/permeability increasing protein against carbohydrate dyshomeostasis and tumor necrosis factor-alpha elevation in rat endotoxemia.
    Lin Y; Kohn FR; Kung AH; Ammons WS
    Biochem Pharmacol; 1994 Apr; 47(9):1553-9. PubMed ID: 8185667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the structural elements in lipid A required for binding of a recombinant fragment of bactericidal/permeability-increasing protein rBPI23.
    Gazzano-Santoro H; Parent JB; Conlon PJ; Kasler HG; Tsai CM; Lill-Elghanian DA; Hollingsworth RI
    Infect Immun; 1995 Jun; 63(6):2201-5. PubMed ID: 7768599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and pharmacologic activity of a new nitrate ester, ITF 296, after intravenous administration in healthy volunteers.
    Sardina M; Love R; Mizrahi J; Monzani V; Bianchini C
    J Cardiovasc Pharmacol; 1995; 26 Suppl 4():S72-9. PubMed ID: 8839230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of bactericidal permeability-increasing protein in the treatment of gram-negative pneumonia.
    Kelly CJ; Cech AC; Argenteanu M; Gallagher H; Shou J; Minnard E; Daly JM
    Surgery; 1993 Aug; 114(2):140-6. PubMed ID: 8342120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple-dose pharmacokinetics of intravenous telavancin in healthy male and female subjects.
    Wong SL; Barriere SL; Kitt MM; Goldberg MR
    J Antimicrob Chemother; 2008 Oct; 62(4):780-3. PubMed ID: 18586659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of a recombinant N-terminal fragment of bactericidal/permeability-increasing protein (rBPI23) on cerebrospinal fluid inflammation induced by endotoxin.
    Kartalija M; Kim Y; White ML; Nau R; Tureen JH; Täuber MG
    J Infect Dis; 1995 Apr; 171(4):948-53. PubMed ID: 7706823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.